Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination

Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination

INTRODUCTION: The leading professional organizations in the field of hematology have recommended severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) vaccination for all patients with hematologic malignancies notwithstanding efficacy concerns. Here we report a systematic literature review re...

Full description

Bibliographic Details
Main Authors:	Akın, S. (Author), Guven, D.C (Author), Sahin, T.K (Author), Uckun, F.M (Author)
Format:	Article
Language:	English
Published:	NLM (Medline) 2022
Subjects:	Antibodies, Viral antibody complication COVID-19 COVID-19 Vaccines drug therapy hematologic disease Hematologic Neoplasms hematological malignancies human Humans meta analysis prevention and control SARS-CoV-2 seroconversion Seroconversion vaccination Vaccination vaccine virus antibody
Online Access:	View Fulltext in Publisher

Similar Items

COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
by: Luigi Cavanna, et al.
Published: (2021-09-01)

COVID-19 vaccines and their potential use in patients with hematological malignancies
by: Ashraf Dada, et al.
Published: (2021-01-01)

Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
by: Fulvia Pimpinelli, et al.
Published: (2021-05-01)

Antibody Responsiveness to Influenza: What Drives It?
by: Xia Lin, et al.
Published: (2021-07-01)

INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY
by: Giuseppe La Torre
Published: (2016-09-01)

Anti-Hepatitis B Antibody Levels In Immunized Medical Students: Are They At Risk?
by: Keila Zaniboni Siqueira Batista, et al.
Published: (2019-05-01)

Strategy to control occupational risk for Hepatitis B: impact on the vaccination and seroconversion rates in dentistry students
by: Daniela Nunes NOGUEIRA, et al.
Published: (2018-03-01)

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination
by: Aberle, J.H, et al.
Published: (2022)

Predictor Factors Affecting Seroconversion Post-Influenza Vaccination in the Elderly
by: Saskia Aziza Nursyirwan, et al.
Published: (2017-12-01)

Seroconversion and adverse reaction of live-attenuated (OKA strain) varicella vaccine
by: Yulchair Ramli, et al.
Published: (2016-09-01)

Evaluation of Antibody Response After Vaccination with Inactivated SARS-CoV-2 Vaccine in Health Workers
by: İsmail Davarcı, et al.
Published: (2021-06-01)

Management of hematological malignancies during the COVID-19 pandemic
by: Aamer Aleem, et al.
Published: (2020-01-01)

Comparison of seroconversion rates between low-dose intradermal and recommended dose intramuscular hepatitis B vaccination in children
by: Sony HA Harsono, et al.
Published: (2016-09-01)

SARS-CoV-2 Antigenemia as a Confounding Factor in Immunodiagnostic Assays: A Case Study
by: Konstantinos Belogiannis, et al.
Published: (2021-06-01)

Screening Strategies for COVID-19 in Patients With Hematologic Malignancies
by: Tarek Assi, et al.
Published: (2020-07-01)

Long-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case report
by: Balint Bela, et al.
Published: (2021-01-01)

Symptoms, antibody levels and vaccination attitude after asymptomatic to moderate COVID-19 infection in 200 healthcare workers
by: Harsch, Igor Alexander, et al.
Published: (2021-04-01)

Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review
by: Zhangkai Jason Cheng, et al.
Published: (2021-08-01)

Correlation of Frailty Status with Influenza Vaccine Seroconversion and Seroprotection among Elderly Population
by: Sukamto Koesnoe, et al.
Published: (2016-12-01)

Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates
by: Labanya Mukhopadhyay, et al.
Published: (2021-01-01)

Role of IgD in prevention and treatment of SARS CoV-2 infection “The Hidden Soldier"
by: Donia Sheir
Published: (2020-07-01)

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
by: Mascellino MT, et al.
Published: (2021-08-01)

Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature
by: Jonathan Douxfils, et al.
Published: (2021-08-01)

Prospective study of hepatitis B virus reactivation in patients with hematological malignancies
by: Maurizio Pompili, et al.
Published: (2015-03-01)

COVID-19 in Hematologic Malignancies: Big Challenges
by: Yongxian Hu, et al.
Published: (2020-10-01)

Retrospective of International Serological Studies on the Formation and Dynamics of the Humoral Immune Response to SARS-CoV-2: from 2020 to 2021
by: E. A. Novikova, et al.
Published: (2021-06-01)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
by: Xin Rong Lim, et al.
Published: (2021-08-01)

A Peptide-Based Assay Discriminates Individual Antibody Response to the COVID-19 Pfizer/BioNTech mRNA Vaccine
by: Immacolata Polvere, et al.
Published: (2021-09-01)

Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19
by: Jiao Tong, et al.
Published: (2021-03-01)

The prevalence of bovine viral diarrhoea antibodies in selected South African dairy herds, and control of the disease
by: G.M. Ferreira, et al.
Published: (2000-07-01)

H1N1 influenza among hematological patients: monocentric influenza cases from 2011 to 2016.
by: Elisabetta Metafuni, et al.
Published: (2017-03-01)

Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
by: Uttpal Anand, et al.
Published: (2021-06-01)

Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers
by: Balfe, P., et al.
Published: (2022)

Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies
by: Zheng Tian, et al.
Published: (2021-05-01)

Antibodies and Vaccines Target RBD of SARS-CoV-2
by: Long Min, et al.
Published: (2021-04-01)

SARS-CoV-2 Gamma and Delta Variants of Concern Might Undermine Neutralizing Activity Generated in Response to BNT162b2 mRNA Vaccination
by: Cipolletta, D., et al.
Published: (2022)

Direct Measurement of B Lymphocyte Gene Expression Biomarkers in Peripheral Blood Transcriptomics Enables Early Prediction of Vaccine Seroconversion
by: Dan Huang, et al.
Published: (2021-06-01)

Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
by: Matthew J. Gorman, et al.
Published: (2021-09-01)

Can vaccines against canine visceral leishmaniasis interfere with the serological diagnostics recommended by the Brazilian Ministry of Health?
by: Monique Paiva de Campos, et al.

Resultados del estudio serológico tras la vacunación frente a Neisseria meningitidis serogrupo C en niños
by: Espín Ríos María Isabel
Published: (2000-01-01)